Letter to the Editor: Battle Won but War Lost for Barth Syndrome Patients
Therapeutic Innovation & Regulatory Science · 2026-05 · 60 (3) · 660-662
DOI: 10.1007/s43441-026-00951-x ↗Kurz gefasst
Leserbrief in der Zeitschrift Therapeutic Innovation & Regulatory Science, online erschienen am 14.03.2026. Verfasst von Norman Stockbridge und 1 weiteren Autor:innen. Beteiligte Einrichtung: S & S Consulting Partners LLC, Silver Spring, USA. norman@stockbridges.org. Die Arbeit nennt 7 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- S & S Consulting Partners LLC, Silver Spring, USA. norman@stockbridges.org.
- S & S Consulting Partners LLC, Silver Spring, USA.
Zitieren
APA
Stockbridge, N., & Southworth, M. R. (2026). Letter to the Editor: Battle Won but War Lost for Barth Syndrome Patients. Therapeutic Innovation & Regulatory Science, 60(3), 660-662. https://doi.org/10.1007/s43441-026-00951-x
Vancouver
Stockbridge N, Southworth MR. Letter to the Editor: Battle Won but War Lost for Barth Syndrome Patients. Therapeutic Innovation & Regulatory Science. 2026;60(3):660-662. doi:10.1007/s43441-026-00951-x
BibTeX
@article{Stockbridge2026,
author = {Stockbridge, Norman and Southworth, Mary Ross},
title = {Letter to the Editor: Battle Won but War Lost for Barth Syndrome Patients},
journal = {Therapeutic Innovation & Regulatory Science},
year = {2026},
volume = {60},
number = {3},
pages = {660--662},
doi = {10.1007/s43441-026-00951-x}
}
EUVIMED